Acute renal failure that is associated with macroscopic
|
|
- Ezra Craig
- 5 years ago
- Views:
Transcription
1 Factors That Determine an Incomplete Recovery of Renal Function in Macrohematuria-Induced Acute Renal Failure of IgA Nephropathy Eduardo Gutiérrez,* Esther González,* Eduardo Hernández,* Enrique Morales,* M. Ángel Martínez, Gabriel Usera, and Manuel Praga* Departments of *Nephrology and Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain Acute renal failure that is associated with macroscopic hematuria (ARF-MH) is a widely known complication of IgA nephropathy (IgAN). Although spontaneous recovery of renal function after cessation of MH has been described, no long-term outcome studies have been performed. The outcome of patients who had biopsy-proven IgAN and presented an ARF-MH episode in the period 1975 through 2005 was studied. Thirty-six episodes of ARF-MH that occurred in 32 patients were identified. A complete recovery of baseline renal function after cessation of MH was observed in 27 (group 1); in the remaining nine episodes (25%; group 2), estimated GFR (egfr) did not reach the baseline value. Final egfr was ml/min per 1.73 m 2 in group 1 patients and ml/min per 1.73 m 2 in group 2 patients (P ). The duration of MH was significantly longer in group 2 patients: versus d (P 0008). A high proportion of tubules that were filled by red blood cell casts and had signs of acute tubular necrosis were the most striking histologic abnormalities. In conclusion, a significant proportion (25%) of ARF-MH in IgAN did not recover the baseline renal function after the disappearance of MH. Duration of MH longer than 10 d, age >50 yr, decreased baseline egfr, absence of previous episodes of MH, and the severity of tubular necrosis were significant risk factors for an incomplete recovery of renal function. Clin J Am Soc Nephrol 2: 51 57, doi: /CJN Acute renal failure that is associated with macroscopic hematuria (ARF-MH) is a widely known complication of IgA nephropathy (IgAN) (1 8). Because the glomerular abnormalities usually are mild, most of the authors agree that hematuria by itself is responsible for the ARF s worsening, through a tubular damage that is induced by intratubular erythrocytic casts and a possible nephrotoxic effect of the hemoglobin that is released by these casts (1 6). Most but not all of the previously reported cases spontaneously showed a complete recovery of baseline renal function. As a consequence, ARF-MH is considered a benign complication of IgAN, although some patients can need short-term hemodialysis as a result of the severity of renal failure. However, no studies have analyzed the long-term evolution of renal function or the factors that influence its recovery after this particular type of ARF. In this study, we analyzed the long-term outcome of 36 episodes of ARF-MH that occurred in 32 patients with IgAN, the largest series gathered so far. Importantly, a considerable proportion (25%) of patients did not recover their previous renal function, arguing against the benign character of this complication that so far has been considered. We analyzed factors that were associated with a lack of renal function recovery. Received July 31, Accepted October 30, Published online ahead of print. Publication date available at Address correspondence to: Dr. Manuel Praga, Servicio de Nefrología, Hospital Universitario 12 de Octubre, Avda. de Córdoba s/n, Madrid, Spain. Phone: ; Fax: ; mpragat@senefro.org Materials and Methods We performed a retrospective analysis of all patients who had biopsy-proven IgAN and presented an ARF-MH in the period 1975 through ARF-MH was defined as an increase of serum creatinine (Scr) of at least 0.5 mg/dl above baseline values that coincided with an episode of MH of glomerular origin. Renal biopsy was obtained in every patient who presented an ARF-MH 3 to 65 d after the onset of macroscopic hematuria ( ). No renal biopsies had been performed in any patient before the appearance of ARF-MH. The diagnosis of IgAN was based on the finding of mesangial glomerulonephritis with predominant mesangial deposits of IgA on immunofluorescence. Patients who received a diagnosis of Schönlein-Henoch purpura, acute or chronic liver diseases, alcoholism, systemic lupus erythematosus, or any other systemic disease were excluded. In all of the patients, the presence of urinary tract infection, including renal tuberculosis, was ruled out by urine cultures. Repeated measurements of 24-h urinary calcium and uric acid excretions were performed to exclude hematuria that was induced by hypercalciuria or hyperuricosuria. Intravenous urographies and ultrasound examination of kidneys and urinary tract were normal in every case. Urine phase-contrast microscopy was performed in 25 (69%) ARF-MH episodes; in every case, 80% of erythrocytes were dysmorphic, indicating a glomerular hematuria. The medical records of the patients were reviewed. All of them had been admitted to the hospital during ARF-MH. All of the patients were discharged after complete resolution of MH, which was defined by the complete and persistent disappearance of dark urine. During hospitalization, macroscopic appearance of urine was examined daily. After resolution of MH, the patients were followed at regular intervals (usually every 2 wk in the first visits and thereafter every 6 mo once Scr remained stable) at our outpatient clinic. The following data at admission were obtained from medical records and analyzed for this study: Copyright 2007 by the American Society of Nephrology ISSN: /
2 52 Clinical Journal of the American Society of Nephrology Clin J Am Soc Nephrol 2: 51 57, 2007 Age, gender, BP, abnormal findings on physical examination, history of previous MH bouts, existence of associated infections that could induce MH, baseline treatment, and day of MH appearance. Analytical study included a complete blood count, routine serum biochemistry profile (including Scr, glucose, uric acid, calcium, phosphorus, sodium, potassium, cholesterol, triglycerides, total proteins, serum albumin, bilirubin, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase), urine sediment examination, urine cultures, 24-h proteinuria, and 24-h urinary excretion of calcium and uric acid. Evolution of these analytical parameters during admission and thereafter during follow-up also were recorded. Estimated GFR (egfr) was calculated by the Modification of Diet in Renal Disease (MDRD-4) formula. All medications that were administered during the ARF-MH, particularly steroids, were recorded carefully, registering their dosage and duration. Duration of MH was determined in every ARF-MH, recording the day of appearance of MH and the day of its disappearance. All patients had at least one Scr determination before the episode of ARF-MH. Last determination of Scr before the onset of MH was defined as baseline Scr. Initial Scr was defined as the value that was obtained at admission. The highest Scr value that was registered during ARF-MH was recorded, as well as the need for acute dialysis. Final Scr was defined as the value that was obtained 6 mo after the episode of ARF-MH. An incomplete recovery of baseline renal function was defined by a Scr value that was higher than at least 25% of the baseline value. Patients were divided in two groups according to whether the recovery of baseline renal function had taken place (group 1, ad integrum recovery of renal function; group 2, incomplete recovery of renal function). Proteinuria levels at the onset of ARF-MH (initial proteinuria), the highest proteinuria value obtained in every case (highest proteinuria), and proteinuria level 6 mo after ARF-MH (final proteinuria) also were recorded. Intervals between onset of MH and highest Scr, cessation of MH and onset of Scr decrease, and cessation of MH and Scr stabilization were calculated in every ARF-MH episode. Renal biopsy specimens were revised for our study by two different pathologists. The severity of mesangial proliferation, interstitial fibrosis, and tubular necrosis was graduated between 0 and (absent, mild, moderate, and severe). The presence of glomerular crescents and red blood cell (RBC) casts that occluded renal tubules was expressed as the percentage of glomeruli or tubules that presented these lesions. Statistical Analyses Data are means SD. For statistical analysis, we used paired and unpaired t test and nonparametric Mann-Whitney test when appropriate. Qualitative variables were analyzed by Fisher test and 2 test. The analysis of data evolution throughout the study period was performed by ANOVA for repeated measurements. Stepwise multiple logistic regression analysis was performed to determine the influence of various parameters on the absence of a complete recovery of baseline renal function. Correlations between quantitative variables were performed with Pearson correlation coefficient. P 0.05 was considered statistically significant. Statistics were calculated using SPSS for Windows, version 11 (SPSS, Chicago, IL). Results Thirty-six episodes of ARF-MH that occurred in 32 patients with biopsy-proven IgAN were identified. Mean age at the onset of ARF-MH was yr (range 18 to 83 yr; Table 1). More than half of the patients (n 19) were older than 50 yr at the onset of episode. Most of the episodes (30 [83%] of 36) occurred in men. A measurement of Scr before the onset of MH (baseline Scr) was available in every episode. In five patients, baseline Scr was 1.3 mg/dl (1.4, 1.4, 1.5, 1.5, and 1.7 mg/dl), expressing a baseline status of chronic renal insufficiency. In the remaining cases, Scr was 1.3 mg/dl. A previous episode of MH was referred by the patient in 47% of ARF-MH. Four patients had two episodes each of ARF-MH. The most common precipitating events of ARF-MH were upper respiratory tract infection in 34%, tonsillitis in 28%, and urinary tract infection in 12%. As expressed in Table 1, mean initial Scr (at admission) was mg/dl (range 0.9 to 12 mg/dl) and highest Scr was mg/dl (range 1.4 to 13.3 mg/dl). Four patients needed several sessions of hemodialysis because of the severity of worsening of renal function. Mean duration of MH was d (range 3 to 75 d). The mean interval between the onset of MH and highest Scr was d (range from 2 to 50 d). Table 1. Clinical characteristics of the 36 episodes of ARF-MH a Characteristic Value Age (yr) (range 18.0 to 83.0) Gender (M/F) 30/6 Baseline egfr (ml/min per 1.73 m 2 ) (range 37 to 156) Baseline Scr (mg/dl) (range 0.7 to 1.7) Initial Scr (mg/dl) (range 0.9 to 12.0) Highest Scr (mg/dl) (range 1.4 to 13.3) Final Scr (mg/dl) (range 0.7 to 2.6) Final egfr (ml/min per 1.73 m 2 ) (range 23 to 154) Initial proteinuria (g/24 h) (range 0.3 to 10.5) Highest proteinuria (g/24 h) (range 0.3 to 11.0) Final proteinuria (g/24 h) (range 0.1 to 3.0) Duration of MH (d) (range 3.0 to 75.0) Interval onset MH, highest Scr (d) (range 2.0 to 50.0) Interval end MH, onset of Scr decrease (d) (range 2.0 to 45.0) a ARF-MH, acute renal failure associated with macroscopic hematuria; egfr, estimated GFR; Scr, serum creatinine.
3 Clin J Am Soc Nephrol 2: 51 57, 2007 Recovery of Renal Function in ARF of IgAN 53 Renal function started to improve after the disappearance of MH in every ARF-MH episode. The mean interval between the end of MH and the onset of Scr decrease was d (range 2 to 45 d). Stabilization of renal function was observed d after the disappearance of MH (see Table 1) A complete recovery of baseline renal function after urine normalization was observed in 27 ARF-MH (group 1). In the remaining nine (25%) episodes (group 2), Scr did not reach the baseline values, remaining at least 25% higher than the baseline values. Final Scr (value of Scr 6 mo after ARF-MH episode) was mg/dl (range 0.7 to 1.4 mg/dl) in group 1 patients and mg/dl (range 1.2 to 2.6 mg/dl) in group 2 patients (P ). Clinical characteristics of group 1 and group 2 are shown in Table 2. Group 2 patients were significantly older than those of group 1 ( versus yr; P 0,01). Baseline Scr was higher in group 2 ( versus mg/dl; P 0.04). The duration of MH was significantly longer in group 2 patients ( versus d; P 0008). A duration of MH longer than 10 d was observed in 88.9% of group 2 patients versus 40.7% in group 1 (P 0.01). The proportion of ARF-MF episodes that lasted 15 d was 77.8% in group 2 and 25.9% in group 1 (P 0.009)). As is shown in Table 2, initial (at admission) Scr and initial proteinuria were significantly higher among group 2 patients. Of the four patients who required acute hemodialysis, an incomplete recovery of baseline Scr (group 2) was observed in two. By univariate analysis, age older than 50 yr, baseline Scr, absence of previous MH episodes, and duration of MH longer than 10 d were the only clinical factors that were statistically associated with the risk for incomplete recovery of previous renal function (Table 3). By multivariate analysis, only a duration of MH longer than 15 d (odds ratio 12.3; 95% confidence interval 1.06 to 143.5; P 0.04) remained as statistically significant risk factor. As expressed in Figure 1, a significant correlation between the duration of MH and the final Scr (Scr 6 mo after the episode of MH) was found (r 0.45; P 0.01). Final Scr was mg/dl after MH longer than 15 d versus mg/dl after episodes shorter than 15 d (P 0.029). Steroid treatment was prescribed in 14 (38.9%) of ARF-MH episodes. The initial dosage usually was 1 mg/kg per d administered orally and then tapered for 2 mo. As is shown in Table 2, there were no significant differences between group 1 and group 2 regarding the percentage of patients who were treated with steroids. By multiple logistic regression analysis, no significant influences of steroid treatment on the recovery of renal function were found. However, steroids in general prescribed were in ARF-MH episodes of long duration: Mean duration of MH before the onset of steroid therapy was (range 5.0 to 75.0) in the 14 episodes of ARF-MH in which they were administered. MH disappeared d (range 1.0 to 45.0 d) after the onset of steroids. A renal biopsy was performed in every ARF-MH episode d (range 3.0 to 65.0) after the onset of MH. Table 4 summarizes the main histologic findings. Glomerular crescents were observed in 15 biopsies (41.8%), but the percentage of glomeruli that were affected by crescents was 25% or less ( glomeruli; range 0.0 to 25.0). The crescents were cellular, small, and segmental in every case, without compression of the glomerular tuft. The glomeruli showed mild or moderate diffuse mesangial proliferation in all of the cases. Neither proliferative necrotizing lesions nor glomeruli with FSGS were observed. The percentage of glomeruli that showed global glomerulosclerosis was higher in group 2 than in group 1 (16.3 versus 4.1%; Table 4) but without statistical significance. Immunofluorescence showed predominant mesangial deposits of IgA in every case. The most striking histologic abnormalities were observed in renal tubules (Figure 2): Almost a half ( %) were filled by Table 2. Clinical characteristics of group 1 (complete recovery of baseline renal function) and group 2 (incomplete recovery) patients Characteristic Group 1 (n 27) Group 2 (n 9) P Age (yr) (18 to 73) (55 to 83) 0.01 Patients 50 yr (%) Gender (M/F) 23/4 7/2 NS Baseline Scr (mg/dl) (0.7 to 1.5) (0.7 to 1.7) 0.04 Baseline egfr (ml/min per 1.73 m 2 ) Highest Scr (mg/dl) (1.4 to 13.3) (4.4 to 12.1) Final Scr (mg/dl) (0.7 to 1.4) (1.2 to 2.6) Final egfr (ml/min per 1.73 m 2 ) Duration of MH (d) (3.0 to 75.0) (7.0 to 75.0) Initial proteinuria (g/d) (0.3 to 10.5) (0.2 to 7.0) NS Final proteinuria (g/d) (0.1 to 1.5) (0.2 to 3.0) 0.03 Steroid treatment (%) NS Previous MH episode (%) Duration of MH 7 d (%) NS Duration of MH 10 d (%) Duration of MH 15 d (%)
4 54 Clinical Journal of the American Society of Nephrology Clin J Am Soc Nephrol 2: 51 57, 2007 Table 3. Variables that influence the risk for an incomplete recovery of renal function a Variable Univariate Analysis Multivariate Analysis P OR 95% CI P OR 95% CI Age 0.46 Age 50 yr to 62.0 NS Gender Baseline Scr to 1.7 NS Baseline egfr to 1.1 NS Previous MH episode to 0.99 NS Severity of tubular necrosis to 37.1 NS Steroid treatment 0.24 Duration of MH 10 d to NS Duration of MH 15 d to to a CI, confidence interval; OR, odds ratio. Figure 1. Correlation between duration of macroscopic hematuria (MH; days) and final serum creatinine (Scr; Scr 6 mo after onset of acute renal failure associated with MH). RBC casts. Signs of acute tubular necrosis (dilation of the lumen, flattening and desquamation of the lining epithelial cells, cytoplasmic degeneration, nuclear pyknosis, and multiple mitosis) were observed in renal tubules, mainly in those that were filled by RBC casts. There was a significant difference in the number of renal biopsies that showed moderate tubular damage in group 1 (28.5%) and group 2 (77.8%; P 0.02), and by univariate analysis, the severity of tubular necrosis was statistically associated with the risk for incomplete recovery of previous renal function (Table 3). No significant differences in the degree of mesangial proliferation, global glomerulosclerosis, crescents, tubules with RBC casts, or interstitial fibrosis were found (Table 4). Table 5 summarizes the main pathologic findings of renal biopsies that were obtained in group 2 patients (incomplete recovery of renal function after MH cessation). Discussion The most salient finding of our study is that a considerable proportion (25%) of patients who had IgAN and experienced an ARF-MH episode do not completely recover the baseline renal function, showing chronic renal insufficiency of variable severity after the resolution of the episode. These findings are important because previous descriptions have reported a spontaneous recovery of normal renal function after cessation of gross hematuria, with no need for any therapeutic intervention (1 8). Bouts of MH are a characteristic complication of IgAN. Most of them are triggered by infections, mainly located in the upper respiratory tract, and may have a recurrent presentation (9,10). Although alarming and disturbing for the patient, the longterm repercussion of these episodes seems to be relatively benign. Studies that have been performed in large cohorts of patients with IgAN have failed to find any long-term detrimental influence of these episodes (11). However, coinciding with an episode of gross hematuria, some patients develop an acute worsening of renal function of variable severity. Although the number of MH bouts that precipitate a severe, oligoanuric, ARF in IgAN is considered to be low, a previous study of our group suggested that milder forms can be more common than suspected (2). Previous descriptions of ARF-MH, including ours, stressed the spontaneous recovery of baseline renal function after cessation of gross hematuria (1 8). Only two cases, previously reported by our group (12), showed a persistent chronic renal insufficiency after an initial improvement of renal function that coincided with the end of MH. In this study, we found that one fourth of the patients in our series did not recover their baseline renal function. Duration of MH was associated with the risk for an incomplete recovery of renal function, by both univariate and multivariate analysis. As is shown in Table 2, all group 2 patients (with an incomplete recovery of renal function) had duration of MH longer than 7 d, and it was longer than 15 d in almost 80% of them. In addition, a significant correlation between the duration of MH and the final Scr was found (Figure 1). However, it should be stressed that age 50 yr, baseline Scr and egfr, and the absence of previous episodes of MH also were significant clinical risk factors by univariate analysis. These findings indicate that previously damaged kidneys (by
5 Clin J Am Soc Nephrol 2: 51 57, 2007 Recovery of Renal Function in ARF of IgAN 55 Table 4. Histologic findings a Finding Group 1 (n 27) Group 2 (n 9) P Mesangial proliferation (%) NS absent mild moderate severe 0 0 Glomeruli with global glomerulosclerosis (%) NS Glomeruli with crescents (%) NS Tubules with RBC casts (%) NS Tubular necrosis (%) 0.02 absent mild moderate severe Interstitial fibrosis (%) NS absent mild moderate severe 0 0 a RBC, red blood cell. Figure 2. Tubules filled by red blood cells, showing diminished number of lining epithelial cells and nuclear pyknosis. Magnification, 250 (hematoxylin-eosin). age or hypertension-related nephrosclerosis) seem to be more sensitive to the detrimental effect of a prolonged MH. The finding of duration of MH as a significant risk factor to determine the recovery of previous renal function agrees well with the pathogenesis proposed for these episodes of ARF: Renal biopsies that are performed during these ARF-MH of IgAN characteristically show important tubular lesions, whereas the glomerular abnormalities cannot explain the acute worsening of renal function (1 6). Tubular abnormalities consist in a high proportion of tubules that are filled by RBC casts and signs of tubular necrosis that are more evident in tubules that are occupied by RBC casts. On the basis of these findings, we and others proposed that glomerular hematuria might damage tubular cells through several mechanisms: Direct tubular obstruction by RBC casts, tubulotoxic effect of hemoglobin or other substances that are released by broken erythrocytes in the tubular lumen, and erythrophagocytosis by tubular epithelial cells (1,2,4,13). In this way, if glomerular bleeding by itself is responsible for ARF-MH episodes through its tubulotoxic effects, then a prolonged duration of hematuria could induce a more severe and partially irreversible tubular damage. Renal tubules of elderly patients with preexisting chronic renal insufficiency might be more unable to recover their functional integrity after such prolonged insult. It is interesting to remark that similar cases of ARF as a result of acute tubular necrosis by RBC casts have been reported in patients with glomerular hematuria caused by glomerular diseases other than IgAN, such as Henoch-Schönlein purpura, acute postinfectious glomerulonephritis, focal necrotizing glomerulonephritis, and Goodpasture syndrome (4,14 16). The histologic findings of our study are in keeping with previous studies of our group and other investigators: A considerable proportion of renal tubules ( %) were filled by RBC casts, and characteristic lesions of acute tubular necrosis were observed mainly in tubules that were occupied by RBC casts. The histologic severity of tubular necrosis was significantly worse in group 2 patients (Table 4), and it was a significant risk factor for an incomplete recovery of renal function (Table 3). Glomerular lesions were mild in general, showing the typical mild or moderate mesangial proliferation of IgAN. It has been reported that renal biopsies that are performed closely to an episode of MH in patients with IgAN show glomerular
6 56 Clinical Journal of the American Society of Nephrology Clin J Am Soc Nephrol 2: 51 57, 2007 Table 5. Histologic findings in group 2 patients (incomplete recovery of renal function) a Patient Duration of MH (d) Mesangial Proliferation %GS % Glomeruli with Crescents % Tubules with RBC Casts Tubular Necrosis Fibrosis Final Scr b (mg/dl) a GS, glomerulosclerosis. b Scr 6 mo after the onset of ARF-MH. crescents in a higher proportion than those that are performed out of gross hematuria bouts (17); however, with the exception of some patients with very aggressive clinical courses, the number of glomeruli that are affected by crescents usually is low. Our study confirms this point: Crescents, when present, affected only a minority of glomeruli. The direct relationship between the duration of MH and the persistence of renal damage that we have found in this study has important clinical implications. According to our data, ARF-MH episodes that last longer than 10 to 15 d, particularly in elderly patients and in patients with previously damaged kidneys, are accompanied by a high risk for an incomplete recovery of baseline renal function. Therefore, therapeutic interventions that aim to reduce the duration of MH clearly would be indicated. The problem is that clinical data about therapeutic interventions that could shorten the duration of gross hematuria episodes in IgAN are scarce. Intuitively, highdosage steroids could induce this effect; however, although steroid administration has proved to be beneficial for the longterm outcome of patients with IgAN (18), its effect on the duration of gross hematuria episodes has not been tested in an appropriate prospective design. In our study, 14 (38.9%) ARF-MH episodes were treated with steroids. No beneficial effect of steroid treatment on the recovery of renal function was observed, but it should be considered that steroids were administered in cases of ARF-MH of longer duration, introducing a bias that invalidates statistical analysis. Our data might suggest, however, that steroid administration shortened the duration of MH: Duration of gross hematuria before the onset of steroid treatment was d in the 14 episodes of ARF-MH that were treated; it disappeared d after the onset of steroid treatment. Therefore, it might be reasonable to recommend the administration of a course of steroids in ARF-MH episodes that are longer than 10 to 15 d, particularly in patients who are older than 50 yr or in those with baseline renal insufficiency, considering the high risk for persistent chronic renal insufficiency after such prolonged episodes and the ominous significance for long-term prognosis of such chronic renal insufficiency in IgAN (19). However, no conclusive recommendations can be extracted from our retrospective data; prospective and randomized trials are necessary to ascertain the influence of steroids in ARF-MH of IgAN. Our study also provides new clinical information about the characteristics of ARF-MH of IgAN. Although the duration of MH episodes is considered to be short usually, resolving in a few days, our study shows that they can be strikingly prolonged, lasting for 2 mo in some cases. In addition, recurring MH episodes are classically considered as a characteristic presentation of young patients in the earlier course of IgAN (9 11). By contrast, more than half of ARF-MH episodes in our study developed in patients who were older than 50 yr, the oldest one being 83 yr of age. Finally, because recurring MH is considered a complication of the earlier stages of IgAN, ARF-MH episodes are thought to appear almost exclusively in patients with baseline normal renal function. Our study shows that this statement is not always correct: Five ARF-MH episodes developed in patients with a Scr 1.3 mg/dl. However, considering the significant number of elderly patients in our cohort, this baseline renal insufficiency might be secondary to age-related nephrosclerosis rather than to advanced IgAN by itself. Conclusion A significant proportion (25%) of ARF-MH in IgAN did not recover the baseline renal function after the disappearance of MH. A longer duration of MH, together with age 50 yr, decreased baseline egfr, the absence of previous MH episodes, and the finding of a severe tubular necrosis in renal biopsy were the most conclusively implicated parameters in this untoward outcome. Acknowledgments Portions of this study were presented at the American Society of Nephrology Renal Week, November 8 through 13, 2005, Philadelphia, PA; and at the Congress of the European Renal Association-European Dialysis and Transplant Association, July 15 to 18, 2006, Glasgow, Scotland. Disclosures None.
7 Clin J Am Soc Nephrol 2: 51 57, 2007 Recovery of Renal Function in ARF of IgAN 57 References 1. Kincaid-Smith P, Bennett WM, Dowling JP, Ryan GB: Acute renal failure and tubular necrosis associated with hematuria due to glomerulonephritis. Clin Nephrol 19: , Praga M, Gutierrez-Millet V, Navas JJ, Ruilope LM, Morales JM, Alcazar JM, Bello I, Rodicio JL: Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy. Kidney Int 28: 69 74, Delclaux C, Jacquot C, Callard P, Kleinknecht D: Acute reversible renal failure with macroscopic haematuria in IgA nephropathy. Nephrol Dial Transplant 8: , Fogazzi GB, Imbasciati E, Moroni G, Scalia A, Mihatsch MJ, Ponticelli C: Reversible acute renal failure from gross haematuria due to glomerulonephritis: Not only in IgA nephropathy and not associated with intratubular obstruction. Nephrol Dial Transplant 10: , Praga M, Costa JR, Shandas GJ, Martinez MA, Miranda B, Rodicio JL: Acute renal failure in cirrhosis associated with macroscopic hematuria of glomerular origin. Arch Intern Med 147: , Packham DK, Hewitson TD, Yan HD, Elliott CE, Nichols K, Becker GJ: Acute renal failure in IgA nephropathy. Clin Nephrol 42: , Talwalkar YB, Price WH, Musgrave JE: Recurrent resolving renal failure in IgA nephropathy. J Pediatr 92: , Francois B, Cohen R: Acute renal failure and IgA nephropathy. Clin Nephrol 19: , Galla JH: IgA nephropathy. Kidney Int 47: , Donadio JV, Grande JP: IgA nephropathy. N Engl J Med 347: , Droz D: Natural history of primary glomerulonephritis with mesangial deposits of IgA. Contrib Nephrol 2: , Mazuecos A, Ramos PC, Campo C, Sanchez R, Martinez MA, Praga M: Chronic renal insufficiency after and episode of macroscopic hematuria in IgA nephropathy. Nephron 64: , Hill PA, Davies DJ, Kincaid-Smith P, Ryan GB: Ultrastructural changes in renal tubules associated with glomerular bleeding. Kidney Int 36: , Kobayashi Y, Omori S, Kamimaki I, Ikeda M, Akaoka K, Honda M, Ogata K, Morikawa Y: Acute reversible renal failure with macroscopic hematuria in Henoch-Schonlein purpura. Pediatr Nephrol 16: , Michail S, Stathakis C, Nakopoulou L, Aroni K, Revenas K, Avdikou K, Vaiopoulos G: Acute renal failure in an adult patient with Henoch-Schonlein episode of macroscopic hematuria. Ren Fail 21: , Walker RG, Becker GJ, d Apice AJ, Kincaid-Smith P: Treatment of oligoanuric anti-gbm nephritis. Lancet 1: Bennett WH, Kincaid-Smith P: Macroscopic hematuria in mesangial nephropathy: Correlation with glomerular crescents and renal dysfunction. Kidney Int 23: , Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, Locatelli F: Corticosteroids in IgA nephropathy: A randomised controlled trial. Lancet 13: , Bartosik LP, Lajoie G, Sugar L, Cattran DC: Predicting progression in IgA nephropathy. Am J Kidney Dis 38: , 2001
Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis
original article http://www.kidney-international.org & 2008 International Society of Nephrology see commentary on page 905 Early steroid treatment improves the recovery of renal function in patients with
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of steroid therapy GUIDELINES
Specific management of IgA nephropathy: role of steroid therapy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES Steroid therapy may protect against progressive
More informationGlomerular pathology in systemic disease
Glomerular pathology in systemic disease Lecture outline Lupus nephritis Diabetic nephropathy Glomerulonephritis Associated with Bacterial Endocarditis and Other Systemic Infections Henoch-Schonlein Purpura
More informationSecondary IgA Nephropathy & HSP
Secondary IgA Nephropathy & HSP Anjali Gupta, MD 1/11/11 AKI sec to Hematuria? 65 cases of ARF after an episode of macroscopic hematuria have been reported in the literature in patients with GN. The main
More informationA clinical syndrome, composed mainly of:
Nephritic syndrome We will discuss: 1)Nephritic syndrome: -Acute postinfectious (poststreptococcal) GN -IgA nephropathy -Hereditary nephritis 2)Rapidly progressive GN (RPGN) A clinical syndrome, composed
More informationAcute renal failure in IgA nephropathy: Aggravation by gross hematuria due to anticoagulant treatment
Table of Contents Case report J NEPHROL 2002; 15: 709-712 Acute renal failure in IgA nephropathy: Aggravation by gross hematuria due to anticoagulant treatment Christian August 1, Andreas Atzeni 2, Ludger
More informationDisorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome.
Disorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome. Azotemia and Urinary Abnormalities Disturbances in urine volume oliguria, anuria, polyuria Abnormalities of urine sediment red
More informationYear 2004 Paper one: Questions supplied by Megan
QUESTION 53 Endothelial cell pathology on renal biopsy is most characteristic of which one of the following diagnoses? A. Pre-eclampsia B. Haemolytic uraemic syndrome C. Lupus nephritis D. Immunoglobulin
More informationCHAPTER 2. Primary Glomerulonephritis
2nd Report of the PRIMARY GLOMERULONEPHRITIS CHAPTER 2 Primary Glomerulonephritis Sunita Bavanandan Lee Han Wei Lim Soo Kun 21 PRIMARY GLOMERULONEPHRITIS 2nd Report of the 2.1 Introduction This chapter
More informationCase # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings
Case # 2 Christopher Larsen, MD Arkana Laboratories Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of tonsillectomy GUIDELINES
Specific management of IgA nephropathy: role of tonsillectomy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES No recommendation possible based on Level I or II
More informationElevated Serum Creatinine, a simplified approach
Elevated Serum Creatinine, a simplified approach Primary Care Update Creighton University School of Medicine. April 27 th, 2018 Disclosure Slide I have no disclosures and have no conflicts with this presentation.
More informationTitle: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy
Author's response to reviews Title: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy Authors: Nan Zhen Dong (dongzn@301hospital.com.cn) Yong
More informationGlomerular diseases mostly presenting with Nephritic syndrome
Glomerular diseases mostly presenting with Nephritic syndrome 1 The Nephritic Syndrome Pathogenesis: proliferation of the cells in glomeruli & leukocytic infiltrate Injured capillary walls escape of RBCs
More informationAtypical IgA Nephropathy
Atypical IgA Nephropathy Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA XXXIII Chilean Congress of Nephrology, Hypertension and Transplantation Puerto Varas, Chile October 6, 2016 IgA
More informationIgA Nephropathy - «Maladie de Berger»
IgA Nephropathy - «Maladie de Berger» B. Vogt, Division de Néphrologie/Consultation d Hypertension CHUV, Lausanne 2011 Montreux CME SGN-SSN IgA Nephropathy 1. Introduction 2. Etiology and Pathogenesis
More informationIntroduction to Clinical Diagnosis Nephrology
Introduction to Clinical Diagnosis Nephrology I. David Weiner, M.D. C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University of Florida College
More informationClassification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus
Classification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus Mark Haas MD, PhD Department of Pathology & Laboratory Medicine Cedars-Sinai Medical
More informationCHAPTER 2 PRIMARY GLOMERULONEPHRITIS
CHAPTER 2 Sunita Bavanandan Lim Soo Kun 19 5th Report of the 2.1: Introduction This chapter covers the main primary glomerulonephritis that were reported to the MRRB from the years 2005-2012. Minimal change
More informationDr P Sigwadi 30 May 2012
Dr P Sigwadi 30 May 2012 Introduction Haematuria Positive blood on urine dipstick 5 red blood cells/ microliter of urine Prevalence Gross haematuria ( macroscopic) 0.13 % Microscopic- 1.5% Haematuria +
More informationClinical Study Glomerulonephritis with Crescents in Children: Etiology and Predictors of Renal Outcome
International Scholarly Research Network ISRN Pediatrics Volume 2011, Article ID 507298, 5 pages doi:10.5402/2011/507298 Clinical Study Glomerulonephritis with Crescents in Children: Etiology and Predictors
More informationThe most widespread type of glomerulonephritis is IgA
CJASN epress. Published on May 28, 2008 as doi: 10.2215/CJN.00310108 Effect of Tonsillectomy Plus Steroid Pulse Therapy on Clinical Remission of IgA Nephropathy: A Controlled Study Hiroyuki Komatsu, Shouichi
More informationCase Presentation Turki Al-Hussain, MD
Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory
More informationTHE URINARY SYSTEM. The cases we will cover are:
THE URINARY SYSTEM The focus of this week s lab will be pathology of the urinary system. Diseases of the kidney can be broken down into diseases that affect the glomeruli, tubules, interstitium, and blood
More informationNephrology Grand Rounds. Mansi Mehta November 24, 2015
Nephrology Grand Rounds Mansi Mehta November 24, 2015 Case 51yo F with PMH significant for Hypertension referred to renal clinic for evaluation of elevated Cr. no known history of CKD; baseline creatinine
More informationProf. Rosanna Coppo Director of the Nephrology, Dialysis and Transplantation Department Regina Margherita Hospital Turin, Italy. Slide 1.
ROLE OF PATHOLOGY AND CLINICAL FEATURES IN PREDICTING PROGRESSION OF IGA NEPHROPATHY: RESULTS FROM THE ERA-EDTA RESEARCH VALIGA Rosanna Coppo, Turin, Italy Chairs: François Berthoux, Saint-Etienne, France
More informationTHE URINARY SYSTEM. The cases we will cover are:
THE URINARY SYSTEM The focus of this week s lab will be pathology of the urinary system. Diseases of the kidney can be broken down into diseases that affect the glomeruli, tubules, interstitium, and blood
More informationTHE KIDNEY AND SLE LUPUS NEPHRITIS
THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS
More informationSurgical Pathology Report
Louisiana State University Health Sciences Center Department of Pathology Shreveport, Louisiana Accession #: Collected: Received: Reported: 6/1/2012 09:18 6/2/2012 09:02 6/2/2012 Patient Name: Med. Rec.
More informationOriginal. IgAN. Key words : IgA nephropathy, IgM deposition, proteinuria, tonsillectomy, steroid pulse therapy. Introduction
Showa Univ J Med Sci 27 3, 167 174, September 2015 Original Prominent IgM Deposition in Glomerulus Is Associated with Severe Proteinuria and Reduced after Combined Treatment of Tonsillectomy with Steroid
More informationFamilial DDD associated with a gain-of-function mutation in complement C3.
Familial DDD associated with a gain-of-function mutation in complement C3. Santiago Rodríguez de Córdoba, Centro de investigaciones Biológicas, Madrid Valdés Cañedo F. and Vázquez- Martul E., Complejo
More informationCHAPTER 4. Paediatric Renal Biopsies
2nd Report of the Malaysian Registry of Renal Biopsy 2008 PAEDIATRIC RENAL BIOPSIES CHAPTER 4 Paediatric Renal Biopsies Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Wan Jazilah Wan Ismail Yap Yok Chin
More informationApproach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis
GLOMERULONEPHRITIDES Vivette D Agati Jai Radhakrishnan Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis Heavy Proteinuria Renal failure Low serum Albumin Hypertension
More informationClinical pathological correlations in AKI
Clinical pathological correlations in AKI Dr. Rajasekara chakravarthi Director - Nephrology Star Kidney Center, Star Hospitals Renown clinical services India Introduction AKI is common entity Community
More informationDIABETES MELLITUS. Kidney in systemic diseases. Slower the progression: Pathology: Patients with diabetes mellitus are prone to other renal diseases:
Kidney in systemic diseases Dr. Badri Paudel The kidneys may be directly involved in a number of multisystem diseases or secondarily affected by diseases of other organs. Involvement may be at a prerenal,
More informationSteroid Resistant Nephrotic Syndrome. Sanjeev Gulati, Debashish Sengupta, Raj K. Sharma, Ajay Sharma, Ramesh K. Gupta*, Uttam Singh** and Amit Gupta
Steroid Resistant Nephrotic Syndrome Sanjeev Gulati, Debashish Sengupta, Raj K. Sharma, Ajay Sharma, Ramesh K. Gupta*, Uttam Singh** and Amit Gupta From the Departments of Nephrology, Pathology* and Biostatistics**,
More informationSpecial Challenges and Co-Morbidities
Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine
More informationClinicopathologic Characteristics of IgA Nephropathy with Steroid-responsive Nephrotic Syndrome
J Korean Med Sci 2009; 24 (Suppl 1): S44-9 ISSN 1011-8934 DOI: 10.3346/jkms.2009.24.S1.S44 Copyright The Korean Academy of Medical Sciences Clinicopathologic Characteristics of IgA Nephropathy with Steroid-responsive
More informationRECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST
RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT J. H. Helderman,MD,FACP,FAST Vanderbilt University Medical Center Professor of Medicine, Pathology and Immunology Medical Director, Vanderbilt Transplant
More informationCase 3. ACCME/Disclosure. Laboratory results. Clinical history 4/13/2016
Case 3 Lynn D. Cornell, M.D. Mayo Clinic, Rochester, MN Cornell.Lynn@mayo.edu USCAP Renal Case Conference March 13, 2016 ACCME/Disclosure Dr. Cornell has nothing to disclose Clinical history 57-year-old
More informationCitation Acta medica Nagasakiensia. 2003, 48
NAOSITE: Nagasaki University's Ac Title Author(s) Renal Outcome of Immunoglobulin A N Horita, Yoshio; Tadokoro, Masato; T Miyazaki, Masanobu; Taguchi, Takash Yoshiyuki; Kohno, Shigeru Citation Acta medica
More informationCrescentic Glomerulonephritis (RPGN)
Crescentic Glomerulonephritis (RPGN) Background Rapidly progressive glomerulonephritis (RPGN) is defined as any glomerular disease characterized by extensive crescents (usually >50%) as the principal histologic
More informationQUICK REFERENCE FOR HEALTHCARE PROVIDERS
KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease
More informationC1q nephropathy the Diverse Disease
C1q nephropathy the Diverse Disease Danica Galešić Ljubanović School of Medicine, University of Zagreb Dubrava University Hospital Zagreb, Croatia Definition Dominant or codominant ( 2+), mesangial staining
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment
Specific management of IgA nephropathy: role of triple therapy and cytotoxic therapy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES a. Triple therapy with cyclophosphamide,
More informationRENAL HISTOPATHOLOGY
RENAL HISTOPATHOLOGY Peter McCue, M.D. Department of Pathology, Anatomy & Cell Biology Sidney Kimmel Medical College There are no conflicts of interest. 1 Goals and Objectives! Goals Provide introduction
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of fish oil
Specific management of IgA nephropathy: role of fish oil Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES Early and prolonged treatment with fish oil may retard
More informationIgA Nephropathy: Morphologic Findings Associated with Disease Progression and Therapeutic Response A Working Group Approach
I IgA Nephropathy: Morphologic Findings Associated with Disease Progression and Therapeutic Response A Working Group Approach Mark Haas Department of Pathology & Lab Medicine Cedars-Sinai Medical Center
More informationInteresting case seminar: Native kidneys Case Report:
Interesting case seminar: Native kidneys Case Report: Proximal tubulopathy and light chain deposition disease presented as severe pulmonary hypertension with right-sided cardiac dysfunction and nephrotic
More informationThe improvement of renal survival with steroid pulse therapy in IgA nephropathy
Nephrol Dial Transplant (2008) 23: 3915 3920 doi: 10.1093/ndt/gfn394 Advance Access publication 20 July 2008 Original Article The improvement of renal survival with steroid pulse therapy in IgA nephropathy
More informationNephrotic syndrome minimal change disease vs. IgA nephropathy. Hadar Meringer Internal medicine B Sheba
Nephrotic syndrome minimal change disease vs. IgA nephropathy Hadar Meringer Internal medicine B Sheba The Case 29 year old man diagnosed with nephrotic syndrome 2 weeks ago and complaining now about Lt.flank
More informationPRINCIPLE OF URINALYSIS
PRINCIPLE OF URINALYSIS Vanngarm Gonggetyai Objective Can explain : the abnormalities detected in urine Can perform : routine urinalysis Can interprete : the results of urinalysis Examination of urine
More informationDr. Ghadeer Mokhtar Consultant pathologists and nephropathologist, KAU
Dr. Ghadeer Mokhtar Consultant pathologists and nephropathologist, KAU CLINICAL HISTORY A 4 year old Saudi girl presented to the ER with generalized body swelling, decrease urine output with passing dark
More informationDr. Rai Muhammad Asghar Head of Paediatric Department BBH Rawalpindi
Dr. Rai Muhammad Asghar Head of Paediatric Department BBH Rawalpindi Acute Post streptococcal Glomerulonephritis Sudden onset of Gross hematuria Edema Hypertension Renal insufficiency Cause of AGN Post
More informationPaediatrics Dr. Bakr Lecture 3 Nephrotic Syndrome
P a g e 1 DEFINITION Paediatrics Dr. Bakr Lecture 3 Nephrotic Syndrome Definition: nephrotic syndrome is a disorder characterized by heavy proteinuria with hypoprpteinimia,hyper lipidemia and edema. It
More informationGlomerular Pathology- 1 Nephrotic Syndrome. Dr. Nisreen Abu Shahin
Glomerular Pathology- 1 Nephrotic Syndrome Dr. Nisreen Abu Shahin The Nephrotic Syndrome a clinical complex resulting from glomerular disease & includes the following: (1) massive proteinuria (3.5 gm /day
More informationSCOTTISH REAL BIOPSY REGISTRY: SURVEY OF NATIVE KIDNEY BIOPSY IN SCOTLAND 2015
Scottish Renal Registry Report SECTION N SCOTTISH REAL BIOPSY REGISTRY: SURVEY OF NATIVE KIDNEY BIOPSY IN SCOTLAND All centres in Scotland were able to provide date of birth, sex (except centre), indication
More informationExamination by dipstick: (Orthotoluidine & organic peroxidase) Hemoglobin free in urine. Hemoglobin from red blood cells in urine.
Examination by dipstick: (Orthotoluidine & organic peroxidase) Hemoglobin free in urine Hemoglobin from red blood cells in urine Myoglobin Normal erythrocyte excretion rate * 0 425.000/12 h. ( mean 65.750
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES
Membranous nephropathy role of steroids Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES There is currently no data to support the use of short-term courses of
More informationLupus Related Kidney Diseases. Jason Cobb MD Assistant Professor Renal Division Emory University School of Medicine October 14, 2017
Lupus Related Kidney Diseases Jason Cobb MD Assistant Professor Renal Division Emory University School of Medicine October 14, 2017 Financial Disclosures MedImmune Lupus Nephritis Kidney Biopsy Biomarkers
More informationHistopathology: Glomerulonephritis and other renal pathology
Histopathology: Glomerulonephritis and other renal pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you
More informationGlomerular pathology-2 Nephritic syndrome. Dr. Nisreen Abu Shahin
Glomerular pathology-2 Nephritic syndrome Dr. Nisreen Abu Shahin 1 The Nephritic Syndrome Pathogenesis: inflammation proliferation of the cells in glomeruli & leukocytic infiltrate Injured capillary walls
More informationRejection or Not? Interhospital Renal Meeting 10 Oct Desmond Yap & Sydney Tang Queen Mary Hospital
Rejection or Not? Interhospital Renal Meeting 10 Oct 2007 Desmond Yap & Sydney Tang Queen Mary Hospital Case Presentation F/61 End stage renal failure due to unknown cause Received HD in private hospital
More informationRENAL EVENING SPECIALTY CONFERENCE
RENAL EVENING SPECIALTY CONFERENCE Harsharan K. Singh, MD The University of North Carolina at Chapel Hill Disclosure of Relevant Financial Relationships No conflicts of interest to disclose. CLINICAL HISTORY
More informationCase Studies: Renal and Urologic Impairments Workshop
Case Studies: Renal and Urologic Impairments Workshop Justine Lee, MD, DBIM New York Life Insurance Co. Gina Guzman, MD, DBIM, FALU, ALMI Munich Re AAIM Triennial October, 2012 The Company You Keep 1 Case
More informationRENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University
RENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University OBJECTIVES By the end of this lecture each student should be able to: Define acute & chronic kidney disease(ckd)
More informationUse of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome
Pediatr Nephrol (2003) 18:833 837 DOI 10.1007/s00467-003-1175-4 BRIEF REPORT Gina-Marie Barletta William E. Smoyer Timothy E. Bunchman Joseph T. Flynn David B. Kershaw Use of mycophenolate mofetil in steroid-dependent
More informationSpontaneous remission of nephrotic syndrome in patients with IgA nephropathy
Nephrol Dial Transplant (2011) 26: 1570 1575 doi: 10.1093/ndt/gfq559 Advance Access publication 14 September 2010 Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy Seung Hyeok
More informationHematuria is the first sign of glomerular
Pediatric isolated haematuria Persistent asymptomatic isolated hematuria in children: clinical and histopathological features and prognosis Chun-Yue Feng, Yong-Hui Xia, Wen-Jin Wang, Jin Xia, Hai-Dong
More informationCase Presentation Turki Al-Hussain, MD
Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory
More information16.1 Risk of UTI recurrence in children
16. UTI prognosis 16.1 Risk of UTI recurrence in children Key question: What is the risk of recurrent UTI in children with no known structural or functional abnormalities of the urinary tract with a first
More informationARTICLE. Abstract. Introduction
163 ARTICLE Primary IgA nephropathy: A ten-year analysis on the renal outcomes and a model for estimating risk of progression B Chacko, GT John, N Neelakantan*, N Balakrishnan, G Meshach, M Kirubakaran,
More informationMayo Clinic/ RPS Consensus Report on Classification, Diagnosis, and Reporting of Glomerulonephritis
Mayo Clinic/ RPS Consensus Report on Classification, Diagnosis, and Reporting of Glomerulonephritis Sanjeev Sethi, MD, PhD Department of Laboratory Medicine and Pathology Disclosure Relevant Financial
More informationCurrent treatment recommendations in children with IgA nephropathy Selçuk Yüksel
Current treatment recommendations in children with IgA nephropathy Selçuk Yüksel Department of Pediatric Nephrology Pamukkale University School of Medicine IgA Nephropathy The most common cause of primary
More informationACUTE GLOMERULONEPHRITIS. IAP UG Teaching slides
ACUTE GLOMERULONEPHRITIS 1 Definition Etiology Pathology/pathogenesis Risk factors Clinical Presentation Investigation Differential Diagnosis Management Outcome/Prognosis Indication for Renal Biopsy Summary
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationDra. Irma Esther del Moral Espinosa Nefrología Pediátrica Hospital Infantil de México Federico Gómez
Dra. Irma Esther del Moral Espinosa Nefrología Pediátrica Hospital Infantil de México Federico Gómez drairma.nefroped@gmail.com Many children with idiopathic nephrotic syndrome initially respond to steroid
More informationNDT Advance Access published August 6, 2008
NDT Advance Access published August 6, 2008 Nephrol Dial Transplant (2008) 1 5 doi: 10.1093/ndt/gfn454 Original Article Combined treatment with renin angiotensin system blockers and polyunsaturated fatty
More informationCase Report Corticosteroids in Patients with IgA Nephropathy and Severe Chronic Renal Damage
Case Reports in Nephrology Volume, Article ID 89, pages doi:.//89 Case Report Corticosteroids in Patients with IgA Nephropathy and Severe Chronic Renal Damage Claudio Pozzi, Francesca Ferrario, Bianca
More informationRandom forest can accurately predict the development of end-stage renal disease in immunoglobulin a nephropathy patients
Original Article Page 1 of 8 Random forest can accurately predict the development of end-stage renal disease in immunoglobulin a nephropathy patients Xin Han 1#, Xiaonan Zheng 2#, Ying Wang 3, Xiaoru Sun
More informationNephritic vs. Nephrotic Syndrome
Page 1 of 18 Nephritic vs. Nephrotic Syndrome Terminology: Glomerulus: A network of blood capillaries contained within the cuplike end (Bowman s capsule) of a nephron. Glomerular filtration rate: The rate
More informationLithium toxicity. Dr Aude Servais Service de Néphrologie adulte Hôpital Necker, Paris
Lithium toxicity Dr Aude Servais Service de Néphrologie adulte Hôpital Necker, Paris Lithium Use of lithium salts as salt substitutes but recall from the marketplace in 1949 Efficient in the treatment
More informationClinicopathologic Correlation in IgA Nephropathy
Clinicopathologic Correlation in IgA Nephropathy David Philibert, MD, FRCPC,* Daniel Cattran, MD, FRCPC,* and Terence Cook, FRCPath Summary: IgA nephropathy is the most common biopsy-proven pattern of
More informationPediatric Nephrology Consult and Referral Guidelines
Pediatric Nephrology Consult and Referral Guidelines Introduction We see children and teens from birth to 21 years. The most common reasons patients are referred to pediatric nephrology services include:
More informationAdvances in the European Validation Study of the Oxford Classification of IgA Nephropathy (VALIGA)
Advances in the European Validation Study of the Oxford Classification of IgA Nephropathy (VALIGA) One of the major aims of the IWG is to facilitate European Nephrologists interested in the area of immune-mediated
More informationHUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE STUDY
Journal of Aging Research & Clinical Practice Volume 6, 2017 J Aging Res Clin Practice 2017;inpress Published online in press HUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE
More informationJournal of Nephropathology
www.nephropathol.com DOI: 10.12860/jnp.2014.22 J Nephropathol. 2014; 3(3): 115-120 Journal of Nephropathology Clinicopathological correlations in lupus nephritis; a single center experience Hamid Nasri
More informationRecurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab
TRANSPLANTATION Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab Khadijeh Makhdoomi, 1,2 Saeed Abkhiz, 1,2 Farahnaz Noroozinia, 1,3
More informationRenal Pathology 1: Glomerulus. With many thanks to Elizabeth Angus PhD for EM photographs
Renal Pathology 1: Glomerulus With many thanks to Elizabeth Angus PhD for EM photographs Anatomy of the Kidney http://www.yalemedicalgroup.org/stw/page.asp?pageid=stw028980 The Nephron http://www.beltina.org/health-dictionary/nephron-function-kidney-definition.html
More informationPOST INFECTIOUS GLOMERULONEPHRITIS (PIGN) Anjali Gupta
POST INFECTIOUS GLOMERULONEPHRITIS (PIGN) Anjali Gupta PIGN One of the oldest recognized renal diseases. Now less commonly seen in industrialized nations, but in the underprivileged world, the burden remains
More information29th Annual Meeting of the Glomerular Disease Collaborative Network
29th Annual Meeting of the Glomerular Disease Collaborative Network Updates on the Pathogenesis IgA Nephropathy and IgA Vasculitis (HSP) J. Charles Jennette, M.D. Brinkhous Distinguished Professor and
More informationCASE OF THE WEEK 1
www.nephro-pathology.com CASE OF THE WEEK 1 Clinical Presentation: A 17 year old Indian boy presented with anasarca, decreased urine output and episodes of nausea and vomiting over the last three weeks.
More informationHenöch Schönlein Purpura nephritis and management. Licia Peruzzi
IPNA-ESPN Junior Master Class Henöch Schönlein Purpura nephritis and management Licia Peruzzi Nephrology Dialysis and Transplantation Regina Margherita Children s Hospital Health and Science University
More informationGlomerular tip adhesions predict the progression of IgA nephropathy
Maeda et al. BMC Nephrology 2013, 14:272 RESEARCH ARTICLE Open Access Glomerular tip adhesions predict the progression of IgA nephropathy Kunihiro Maeda 1, Shogo Kikuchi 2, Naoto Miura 1, Keisuke Suzuki
More informationLong-term follow-up of juvenile acute nonproliferative glomerulitis (JANG)
Pediatr Nephrol (2007) 22:1957 1961 DOI 10.1007/s00467-007-0555-6 BRIEF REPORT Long-term follow-up of juvenile acute nonproliferative glomerulitis (JANG) Teruo Fujita & Kandai Nozu & Kazumoto Iijima &
More informationCase Report A Case of Proliferative Glomerulonephritis with Monoclonal IgG Deposits That Showed Predominantly Membranous Features
Hindawi Case Reports in Nephrology Volume 2017, Article ID 1027376, 5 pages https://doi.org/10.1155/2017/1027376 Case Report A Case of Proliferative Glomerulonephritis with Monoclonal IgG Deposits That
More informationDr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust
Dr Ian Roberts Oxford Oxford Pathology Course 2010 for FRCPath Present the basic diagnostic features of the commonest conditions causing proteinuria & haematuria Highlight diagnostic pitfalls Nephrotic
More informationDr Ian Roberts Oxford
Dr Ian Roberts Oxford Oxford Pathology Course 2010 for FRCPath Present the basic diagnostic features of the commonest conditions causing renal failure Highlight diagnostic pitfalls. Crescentic GN: renal
More informationAcute Kidney Injury. I. David Weiner, M.D. Division of Nephrology, Hypertension and Transplantation University of Florida and NF/SGVHS
Acute Kidney Injury I. David Weiner, M.D. Division of Nephrology, Hypertension and Transplantation University of Florida and NF/SGVHS 374-6102 David.Weiner@medicine.ufl.edu www.renallectures.com Concentration
More information